Abstract: TH-PO777
Factors Associated with Gastrointestinal Bleeding in ESRD Patients
Session Information
- Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular - I
November 02, 2017 | Location: Hall H, Morial Convention Center
Abstract Time: 10:00 AM - 10:00 AM
Category: Dialysis
- 607 Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular
Authors
- Blanchard, Thomas C, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Nash-Hampton, Teresa A, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Goulatia, Ashish, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Ray, Jay, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Usvyat, Len A., Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Maddux, Dugan, Fresenius Medical Care North America, Waltham, Massachusetts, United States
- Maddux, Franklin W., Fresenius Medical Care North America, Waltham, Massachusetts, United States
Background
Gastrointestinal (GI) bleeding is a serious problem among patients with End Stage Renal Disease (ESRD), affecting this population at rates almost two orders of magnitude higher than in the general population (Yang et al., 2012). We aimed to characterize the demographic, treatment, and laboratory parameters in dialysis patients with GI bleeds and build prediction models that could identify patients at a higher risk of experiencing a GI bleed.
Methods
We analyzed data on all dialysis patients treated at Fresenius Medical Care North America dialysis clinics as of December 2016. We used a logistic regression with 40 variables including demographics, comorbidities, treatment parameters and laboratories to identify factors highly associated with GI bleeds and measured the effect size. Variables on treatment and laboratory parameters were determined from mean values at 90 to 183 days prior to December 2016.
Results
We studied data from 141,973 dialysis patients, of which 0.7% were diagnosed with a GI bleed. We found that lower hemoglobin, calcium, and transferrin saturation (TSAT) values were associated with GI bleeds. Variability in calcium and hemoglobin (using standard deviation) was also associated with GI bleeds. Further, GI bleeds were more common among those diagnosed with ulcers and with older patients. When tested on a held-out set of 50% of the data, the model was able to accurately predict which patients have a GI bleed with a receiver operating characteristic area under the curve of 0.81.
Conclusion
Our analysis identifies several factors associated with GI bleeds in dialysis patients, which may be useful for predicting patients who are likely to experience a GI bleed. Further research validating the accuracy of the prediction of patients with GI bleed is needed to confirm these findings.
Funding
- Commercial Support – Fresenius Medical Care North America